BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 29846759)

  • 1. The program of antiviral agents inhibits virus infection.
    Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG
    Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial overview: Engineering for viral resistance.
    von Brunn A
    Curr Opin Virol; 2015 Oct; 14():v-vii. PubMed ID: 26320757
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial overview: antivirals and resistance: advances and challenges ahead.
    Menéndez-Arias L; Richman DD
    Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of virus assembly.
    Perlmutter JD; Hagan MF
    Annu Rev Phys Chem; 2015 Apr; 66():217-39. PubMed ID: 25532951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human viral diseases: what is next for antiviral drug discovery?
    De Clercq E
    Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference & inhibition of viruses.
    Gadkari DA
    Indian J Med Res; 2005 Mar; 121(3):147-50. PubMed ID: 15802755
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses.
    Wang X; Zou P; Wu F; Lu L; Jiang S
    Front Med; 2017 Dec; 11(4):449-461. PubMed ID: 29170916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human- and virus-encoded microRNAs as potential targets of antiviral therapy.
    Kurzyńska-Kokorniak A; Jackowiak P; Figlerowicz M; Figlerowicz M
    Mini Rev Med Chem; 2009 Jul; 9(8):927-37. PubMed ID: 19601888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staying ahead of viruses: a never ending task.
    Lamarre D; Wainberg MA
    Curr Opin Virol; 2012 Oct; 2(5):569-71. PubMed ID: 23025913
    [No Abstract]   [Full Text] [Related]  

  • 10. Broad-Spectrum Antivirals and Antiviral Drug Combinations.
    Oksenych V; Kainov DE
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular genetic aspects of interferon induction and antiviral action].
    Bazhan SI; Belova OE
    Vestn Ross Akad Med Nauk; 1998; (3):18-24. PubMed ID: 9608271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acid-based drugs against emerging zoonotic viruses.
    Wong JP
    Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New horizons for antiviral drug discovery from virus-host protein interaction networks.
    de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
    Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
    Naesens L; Zoulim F
    Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.
    Wagner A; Bock CT; Fechner H; Kurreck J
    Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic Potential of Spirooxindoles as Antiviral Agents.
    Ye N; Chen H; Wold EA; Shi PY; Zhou J
    ACS Infect Dis; 2016 Jun; 2(6):382-92. PubMed ID: 27627626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.
    Randall RE; Goodbourn S
    J Gen Virol; 2008 Jan; 89(Pt 1):1-47. PubMed ID: 18089727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abstracts of the 19th International Conference on Antiviral Research (ICAR), San Juan, Puerto Rico, May 7-11, 2006.
    Antiviral Res; 2006 May; 70(1):A26-89. PubMed ID: 16696114
    [No Abstract]   [Full Text] [Related]  

  • 19. Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems.
    Trevisan M; Sinigaglia A; Desole G; Berto A; Pacenti M; Palù G; Barzon L
    Viruses; 2015 Jul; 7(7):3835-56. PubMed ID: 26184286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Status and prospects of the chemotherapy of viral infections].
    Pershin GN
    Farmakol Toksikol; 1975; 38(5):517-27. PubMed ID: 1183580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.